Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)

Trial Profile

Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Nov 2018

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Acute heart failure; Decompensated heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms ASCEND-HF
  • Sponsors Janssen-Cilag; Scios
  • Most Recent Events

    • 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association
    • 03 Aug 2018 Results published in the American Journal of Cardiology.
    • 20 Dec 2017 Results published in the European Journal of Heart Failure
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top